Full-time postdoctoral research appointment in glioblastoma research at WEHI and within the Brain Cancer Centre network. The Ross Laybutt Fellowship supports an early-career researcher through significant brain-cancer projects, new experimental skills, mentorship, leadership development and scientific networking. The initial appointment lasts two years; any later fellowship-supported employment depends on funding and future recruitment processes. The advertised Research Employee Level A6–A8 salary is AUD 107,194–115,059, with 12% superannuation and an additional matching contribution of up to
In Medicine and Neuroscience
Astrocytes release glutamate by regulated exocytosis in health and disease
Vladimir Parpura · Distinguished Professor Zhejiang Chinese Medical University and Director of the International Translational Neuroscience Research Institute, Hangzhou, P.R. China
Thu, Jun 5, 2025 · 15:00 UTC
Astrocytes release glutamate by regulated exocytosis in health and disease Vladimir Parpura, International Translational Neuroscience Research Institute, Zhejiang Chinese Medical University, Hangzhou, P.R. China Parpura will present you with the evidence that astrocytes, a subtype of glial cells in the brain, can exocytotically release the neurotransmitter glutamate and how this release is regulated. Spatiotemporal characteristic of vesicular fusion that underlie glutamate release in astrocytes will be discussed. He will also present data on a translational project in which this release pathwa
MBI Webinar on preclinical research into brain tumours and neurodegenerative disorders
Ekaterina (Caty) Salimova and Ms Sanjeevini Babu Reddiar
Wed, Apr 13, 2022 · 20:30 UTC
WEBINAR 1 Breaking the barrier: Using focused ultrasound for the development of targeted therapies for brain tumours presented by Dr Ekaterina (Caty) Salimova, Monash Biomedical Imaging Glioblastoma multiforme (GBM) - brain cancer - is aggressive and difficult to treat as systemic therapies are hindered by the blood-brain barrier (BBB). Focused ultrasound (FUS) - a non-invasive technique that can induce targeted temporary disruption of the BBB – is a promising tool to improve GBM treatments. In this webinar, Dr Ekaterina Salimova will discuss the MRI-guided FUS modality at MBI and her research